These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 21868517)
1. Modulation of cisplatin cytotoxicity due to its combination with bortezomib and the nature of its administration. Al-Eisawi Z; Beale P; Chan C; Yu JQ; Huq F Anticancer Res; 2011 Sep; 31(9):2757-62. PubMed ID: 21868517 [TBL] [Abstract][Full Text] [Related]
2. Synergism from sequenced combinations of curcumin and epigallocatechin-3-gallate with cisplatin in the killing of human ovarian cancer cells. Yunos NM; Beale P; Yu JQ; Huq F Anticancer Res; 2011 Apr; 31(4):1131-40. PubMed ID: 21508356 [TBL] [Abstract][Full Text] [Related]
3. Combinations of platinums and selected phytochemicals as a means of overcoming resistance in ovarian cancer. Huq F; Yu JQ; Beale P; Chan C; Arzuman L; Nessa MU; Mazumder ME Anticancer Res; 2014 Jan; 34(1):541-5. PubMed ID: 24403514 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and activity of a trinuclear platinum complex: [{trans-PtCl(NH3)2}2mu-{trans-Pt(3-hydroxypyridine)2(H2N(CH2)6NH2)2}]Cl4 in ovarian cancer cell lines. Tayyem H; Huq F; Yu JQ; Beale P; Fisher K ChemMedChem; 2008 Jan; 3(1):145-51. PubMed ID: 17963210 [TBL] [Abstract][Full Text] [Related]
5. Monofunctional Platinum-containing Pyridine-based Ligand Acts Synergistically in Combination with the Phytochemicals Curcumin and Quercetin in Human Ovarian Tumour Models. Arzuman L; Beale P; Yu JQ; Huq F Anticancer Res; 2015 May; 35(5):2783-94. PubMed ID: 25964558 [TBL] [Abstract][Full Text] [Related]
6. Studies on combinations of platinum with paclitaxel and colchicine in ovarian cancer cell lines. Yunos NM; Beale P; Yu JQ; Strain D; Huq F Anticancer Res; 2010 Oct; 30(10):4025-37. PubMed ID: 21036717 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of a monofunctional platinum compound and its activity alone and in combination with phytochemicals in ovarian tumor models. Arzuman L; Beale P; Yu JQ; Proschogo N; Huq F Anticancer Res; 2014 Dec; 34(12):7077-90. PubMed ID: 25503135 [TBL] [Abstract][Full Text] [Related]
8. Synergism from combination of cisplatin and a trans-platinum compound in ovarian cancer cell lines. Alshehri A; Beale P; Yu JQ; Huq F Anticancer Res; 2010 Nov; 30(11):4547-53. PubMed ID: 21115904 [TBL] [Abstract][Full Text] [Related]
9. Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cells. Han I; Ling YH; al-Baker S; Khokhar AR; Perez-Soler R Cancer Res; 1993 Oct; 53(20):4913-9. PubMed ID: 8402681 [TBL] [Abstract][Full Text] [Related]
10. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model. Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121 [TBL] [Abstract][Full Text] [Related]
11. Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models. Al-Eisawi Z; Beale P; Chan C; Yu JQ; Huq F J Ovarian Res; 2013 Nov; 6(1):78. PubMed ID: 24209693 [TBL] [Abstract][Full Text] [Related]
12. Role of carrier ligand in platinum resistance of human carcinoma cell lines. Schmidt W; Chaney SG Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361 [TBL] [Abstract][Full Text] [Related]
13. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance. Sharp SY; Rogers PM; Kelland LR Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070 [TBL] [Abstract][Full Text] [Related]
14. Changes in the in vitro activity of platinum drugs when administered in two aliquots. Al-Eisawi Z; Beale P; Chan C; Yu JQ; Proschogo N; Molloy M; Huq F BMC Cancer; 2016 Aug; 16(1):688. PubMed ID: 27566066 [TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin gallate acts synergistically in combination with cisplatin and designed trans-palladiums in ovarian cancer cells. Mazumder ME; Beale P; Chan C; Yu JQ; Huq F Anticancer Res; 2012 Nov; 32(11):4851-60. PubMed ID: 23155251 [TBL] [Abstract][Full Text] [Related]
16. Combinations of resveratrol, cisplatin and oxaliplatin applied to human ovarian cancer cells. Nessa MU; Beale P; Chan C; Yu JQ; Huq F Anticancer Res; 2012 Jan; 32(1):53-9. PubMed ID: 22213288 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterisation, activities, cell uptake and DNA binding of [[trans-PtCl(NH3)2] [mu-(H2N(CH2)6NH2)] [trans-PdCl(NH3)2](NO3)Cl. Huq F; Daghriri H; Yu JQ; Tayyem H; Beale P; Zhang M Eur J Med Chem; 2004 Nov; 39(11):947-58. PubMed ID: 15501544 [TBL] [Abstract][Full Text] [Related]
18. Synergism from combinations of tris(benzimidazole) monochloroplatinum(II) chloride with capsaicin, quercetin, curcumin and cisplatin in human ovarian cancer cell lines. Arzuman L; Beale P; Chan C; Yu JQ; Huq F Anticancer Res; 2014 Oct; 34(10):5453-64. PubMed ID: 25275041 [TBL] [Abstract][Full Text] [Related]
19. Studies on combination of platinum drugs cisplatin and oxaliplatin with phytochemicals anethole and curcumin in ovarian tumour models. Nessa MU; Beale P; Chan C; Yu JQ; Huq F Anticancer Res; 2012 Nov; 32(11):4843-50. PubMed ID: 23155250 [TBL] [Abstract][Full Text] [Related]
20. Enhanced delivery of cisplatin to intraperitoneal ovarian carcinomas mediated by the effects of bortezomib on the human copper transporter 1. Jandial DD; Farshchi-Heydari S; Larson CA; Elliott GI; Wrasidlo WJ; Howell SB Clin Cancer Res; 2009 Jan; 15(2):553-60. PubMed ID: 19147760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]